Literature DB >> 16319324

Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives.

A T van der Ploeg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16319324     DOI： 10.1183/09031936.05.00112005

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report.

Authors:  David J Birnkrant; Mahi Lakshmi Ashwath; Garey H Noritz; Michelle C Merrill; Tushar A Shah; Carol A Crowe; Robert C Bahler
Journal:  J Child Neurol       Date:  2010-05-25       Impact factor: 1.987

2.  Combined general and epidural anesthesia for major abdominal surgery in a patient with Pompe disease.

Authors:  Won Sung Kim; Ah Reum Cho; Jung Min Hong; Eun Soo Kim; Sung Chun Park; Ji Young Yoon; Tae Kyun Kim
Journal:  J Anesth       Date:  2010-07-09       Impact factor: 2.078

Review 3.  Consensus treatment recommendations for late-onset Pompe disease.

Authors:  Edward J Cupler; Kenneth I Berger; Robert T Leshner; Gil I Wolfe; Jay J Han; Richard J Barohn; John T Kissel
Journal:  Muscle Nerve       Date:  2011-12-15       Impact factor: 3.217

4.  Fatigue: an important feature of late-onset Pompe disease.

Authors:  Marloes L C Hagemans; Sabine P M van Schie; A Cecile J W Janssens; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

Review 5.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

6.  Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition.

Authors:  Manfred Hauben; Eric Y Hung
Journal:  Int J Med Sci       Date:  2013-06-13       Impact factor: 3.738

7.  Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease.

Authors:  Mitja Jevnikar; Metka Kodric; Fabiana Cantarutti; Rossella Cifaldi; Cinzia Longo; Rossana Della Porta; Bruno Bembi; Marco Confalonieri
Journal:  Mol Genet Metab Rep       Date:  2015-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.